Israel - hebraico - Ministry of Health

sanofi israel ltd - cabazitaxel - תרכיז וממס להכנת תמיסה לאינפוזיה - cabazitaxel 60 mg / 1.5 ml - cabazitaxel - cabazitaxel - in combination with prednisone for the treatment of patients with metastatic hormone refractory prostate cancer (mhrpc) previously treated with a docetaxel-based treatment regimen

Israel - hebraico - Ministry of Health

roche pharmaceuticals (israel) ltd - pertuzumab - תרכיז להכנת תמיסה לאינפוזיה - pertuzumab 420 mg / 14 ml - pertuzumab - pertuzumab - perjeta is indicated in combination with trastuzumab and docetaxel for the treatment of patients with her2 positive metastatic breast cancer who have not received prior anti-her2 therapy or chemotherapy for metastatic disease.

Israel - hebraico - Ministry of Health

bioavenir ltd, israel - azithromycin as dihydrate - אבקה להכנת תמיסה מרוכזת לעירוי - azithromycin as dihydrate 500 mg/vial - azithromycin

Israel - hebraico - Ministry of Health

j-c health care ltd - pimozide - טבליה - pimozide 4 mg - pimozide - pimozide - neuroleptic.

Israel - hebraico - Ministry of Health

euromar ltd - diclazuril 2.5 mg/ml - suspension - for the prevention of coccidiosis due to eimeria crandalis and eimeria ovinoidalis in lambs. prevention of coccidiosis due to eimeria bovis and eimeria zuernii in calves.

Israel - hebraico - Ministry of Health

j-c health care ltd - mebendazole - טבליה - mebendazole 100 mg - mebendazole

Israel - hebraico - Ministry of Health

raz pharmaceutics ltd, israel - lidocaine - תמיסה - lidocaine 100 mg / 1 ml - lidocaine

Israel - hebraico - Ministry of Health

raz pharmaceutics ltd, israel - lidocaine hydrochloride - ג'ל - lidocaine hydrochloride 2 %w/w - lidocaine

Israel - hebraico - Ministry of Health

sanofi - aventis israel ltd - cabazitaxel 60 mg / 1.5 ml - concentrate for solution for infusion - cabazitaxel - in combination with prednisone for the treatment of patients with metastatic hormone refractory prostate cancer (mhrpc) previously treated with a docetaxel-based treatment regimen

Israel - hebraico - Ministry of Health

sanofi - aventis israel ltd - cabazitaxel 60 mg / 1.5 ml - concentrate for solution for infusion - cabazitaxel - in combination with prednisone for the treatment of patients with metastatic hormone refractory prostate cancer (mhrpc) previously treated with a docetaxel-based treatment regimen